The incentive to publish negative studies: How beta-blockers and depression got stuck in the publication cycle

Journal of Clinical Epidemiology

Volumn 65, Issue 5, 2012, Pages 488-492

  Luijendijk, Hendrika J ^a,b   Koolman, Xander ^c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Beta blockers; Depression; Publication bias; Publication cycle; Review; Side effects

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDRALAZINE; PROPRANOLOL;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; EMBASE; FALSE POSITIVE RESULT; HUMAN; LONGITUDINAL STUDY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUBLICATION; REFERENCE DATABASE; RISK ASSESSMENT; TREND STUDY; BIBLIOGRAPHIC DATABASE; CHEMICALLY INDUCED DISORDER; LABORATORY DIAGNOSIS; MOTIVATION; PUBLISHING; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DATABASES, BIBLIOGRAPHIC; DEPRESSION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; LONGITUDINAL STUDIES; META-ANALYSIS AS TOPIC; MOTIVATION; PERIODICALS AS TOPIC; PUBLICATION BIAS; PUBLISHING; RISK FACTORS;

EID: 84861115032     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.06.022     Document Type: Article

References (30)

1. Waal HJ. Propranolol-induced depression. Br Med J 1967;2:50.
2. Steffensmeier JJ, Ernst ME, Kelly M, Hartz AJ. Do randomized controlled trials always trump case reports? A second look at propranolol and depression. Pharmacotherapy 2006;26:162-7.
3. Patten SB, Love EJ. Can drugs cause depression? A review of the evidence. J Psychiatry Neurosci 1993;18(3):92-102.
4. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986;255:357-60.
5. Bartels D, Glasser M, Wang A, Swanson P. Association between depression and propranolol use in ambulatory patients. Clin Pharm 1988;7:146-50.
6. Bright RA, Everitt DE. Beta-blockers and depression. Evidence against an association. JAMA 1992;267:1783-7.
7. Carney RM, Rich MW, te Velde A, Saini J, Clark K, Freedland KE. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med 1987;83:223-6.
8. Crane PB, Oles KS, Kennedy-Malone L. Beta-blocker medication usage in older women after myocardial infarction. J Am Acad Nurse Pract 2006;18:463-70.
9. Dhondt TD, Beekman AT, Deeg DJ, Van Tilburg W. Iatrogenic depression in the elderly. Results from a community-based study in the Netherlands. Soc Psychiatry Psychiatr Epidemiol 2002;37(8): 393-8.
10. Gerstman BB, Jolson HM, Bauer M, Cho P, Livingston JM, Platt R. The incidence of depression in new users of beta-blockers and selected antihypertensives. J Clin Epidemiol 1996;49:809-15.
11. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996;7:478-84.
12. Johnell K, Fastbom J. The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol 2008;64:1119-24.
13. Johnson JA, Wallace SM. Investigating the relationship between beta-blocker and antidepressant use through linkage of the administrative databases of Saskatchewan Health. Pharmacoepidemiol Drug Saf 1997;6:1-11.
14. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Topical beta-blockers are not associated with an increased risk of treatment for depression. Ophthalmology 2006;113:1077-80.
15. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288:351-7.
16. Luijendijk H, van den Berg JF, Hofman A, Tiemeier H, Stricker BH. Beta-blockers and the risk of incident depression in the elderly. J Clin Psychopharmacol 2011;31:45-50.
17. Patten SB. Propranolol and depression: evidence from the antihyper-tensive trials. Can J Psychiatry 1990;35:257-9.
18. Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population. Compr Psychiatry 2001;42(2): 124-31.
19. Patten SB, Williams JV, Love EJ. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry 1996;41:469-76.
20. Prisant LM, Spruill WJ, Fincham JE, Wade WE, Carr AA, Adams MA. Depression associated with antihypertensive drugs. J Fam Pract 1991;33(5):481-5.
21. Rathmann W, Haastert B, Roseman JM, Giani G. Cardiovascular drug prescriptions and risk of depression in diabetic patients. J Clin Epidemiol 1999;52:1103-9.
22. Ried LD, Johnson RE, McFarland BH, Brody KK. Antihypertensive drug use and the risk of depression among older hypertensives in an HMO. J Pharmacoepidemiol 2000;8(1):1-28.
23. Schleifer SJ, Slater WR, Macari-Hinson MM, Coyle DA, Kahn M, Zucker HD, et al. Digitalis and beta-blocking agents: effects on depression following myocardial infarction. Am Heart J 1991;121: 1397-402.
24. Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med 1990;150:2286-90.
25. van Melle JP, Verbeek DE, vanden Berg MP, Ormel J, van derLinde MR, de Jonge P. Beta-blockers and depression after myocardial infarction: a multicenter prospective study. J Am Coll Cardiol 2006;48:2209-14.
26. Ried LD, McFarland BH, Johnson RE, Brody KK. Beta-blockers and depression: the more the murkier? Ann Pharmacother 1998;32: 699-708.
27. Sorensen HT, Mellemkjaer L, Olsen JH. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angioten-sin converting enzyme inhibitors. Br J Clin Pharmacol 2001;52(3): 313-8.
28. Callreus T, Agerskov Andersen U, Hallas J, Andersen M. Cardiovascular drugs and the risk of suicide: a nested case-control study. Eur J Clin Pharmacol 2007;63:591-6.
29. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
30. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2(8):e124.